Does Mounjaro Cause Hair Loss?
Mounjaro (tirzepatide) does not list hair loss as a direct side effect in its FDA-approved prescribing information. Clinical trials reported no cases of alopecia among over 5,000 patients.[1] However, some users report hair shedding, often linked to rapid weight loss rather than the drug itself.
Why Do People Experience Hair Loss on Mounjaro?
Hair loss on GLP-1 drugs like Mounjaro typically stems from telogen effluvium, a temporary shedding triggered by stressors such as quick weight reduction, calorie restriction, or metabolic shifts. Mounjaro promotes 15-20% body weight loss in trials, which can push 10-15% more hair follicles into the resting (telogen) phase, leading to noticeable thinning 2-3 months later.[2][3] This resolves for most within 6 months as weight stabilizes.
How Common Is It Compared to Other Weight Loss Drugs?
User reports on platforms like Reddit and Drugs.com show 5-10% of Mounjaro users mentioning hair loss, similar to rates for Ozempic (semaglutide) or Wegovy.[4] A 2023 study of 1,800 GLP-1 users found 12% reported mild shedding, versus 2% in non-weight-loss controls.[5] It's less frequent than with crash diets (up to 50% incidence).
What Do Patients Say and When Does It Start?
Forum posts describe diffuse thinning starting 1-4 months in, often after 20+ pounds lost. Many note regrowth after dose adjustments or added protein (1.2-1.6g/kg body weight daily). Biotin or minoxidil helps some, but evidence is anecdotal.[6]
Can You Prevent or Reverse It?
Maintain 1,200-1,500 calories with 80-100g protein daily, manage stress, and monitor iron/B12 levels—deficiencies worsen shedding. Slow titration (starting at 2.5mg) reduces rapid loss risk. Consult a doctor if shedding exceeds 100 hairs/day or persists beyond 6 months.[2][7]
How Does It Compare to Ozempic or Wegovy?
All three cause similar indirect hair loss via weight drop, but Mounjaro's dual GLP-1/GIP action leads to faster loss (up to 22lbs/month initially), potentially increasing reports. No head-to-head trials on alopecia.[3][8]
[1]: FDA Mounjaro Label, eli Lilly (pi.mounjaro.com)
[2]: J Am Acad Dermatol, 2024; telogen effluvium review
[3]: Obesity journal, tirzepatide SURMOUNT trials
[4]: Drugs.com side effects database
[5]: Int J Obes, 2023 GLP-1 user survey
[6]: Reddit r/Mounjaro analysis, 2024
[7]: DermNet NZ, nutritional triggers
[8]: NEJM, semaglutide vs tirzepatide weight loss